Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

Chemotherapeutic development strategies for schistosomiasis
Book Item (Buchkapitel, Lexikonartikel, jur. Kommentierung, Beiträge in Sammelbänden)
ID 63431
Author(s) Caffrey, C. R.; Williams, D. L.; Todd, M. J.; Nelson, D. L.; Keiser, J.; Utzinger, J.; Selzer, P. M.
Author(s) at UniBasel Keiser, Jennifer
Utzinger, Jürg
Year 2009
Title Chemotherapeutic development strategies for schistosomiasis
Editor(s) Selzer,P.M.
Book title Antiparasitic and Antibacterial drug discovery
Publisher Wiley-Blackwell
Place of publication Weinheim
Pages S. 301-321
ISSN/ISBN 978-3-527-32327-2
Series title Drug discovery in infectious diseases
Number [Vol. 1.]
Keywords and, development, DISCOVERY, disease, DRUG, in, schistosomiasis, strategy
Abstract Schistosomiasis is endemic in 76 countries and territories and infects more than 200 million individuals with almost 800 million people at risk of infection. As a neglected tropical disease, therapy and control relies on just one drug, praziquantel (PZQ). The dependency on a single drug is of considerable concern should development of clinically relevant resistance arise and spread. Accordingly, this chapter summarizes the current state-of-the-art in the development of new antischistosomal small molecules. Attention is also given to molecules that are either in the clinic (e.g., semisynthetic artemisinin derivatives) or under preclinical development (e.g., PZQ analogs, synthetic trioxolanes, alkylaminoalkanethiosulfuric acids). Further, the chapter summarizes efforts to identify lead molecules to validated drug targets (e.g., redox enzymes, cysteine proteases), and finally, the novel application of higher-throughput screening as part of the "hit" identification process.
Full Text on edoc No
Digital Object Identifier DOI 10.1002/9783527626816.ch16
ISI-number WOS:000288598300018

MCSS v5.8 PRO. 0.334 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |